PuSH - Publikationsserver des Helmholtz Zentrums München

101 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Banga, J.* et al.: Predictive modeling, applied to genetically engineered mouse models of breast or lung cancer, provides insights into major oncogenic pathways. Cancer Res. 80, 35-35 (2020)
3.
Bianco, G.* et al.: HOXA13 drives hepatocytes proliferation and liver tumorigenesis in mice. Cancer Res. 79 (2019)
4.
Ron, A. ; Dean-Ben, X.L. ; Gottschalk, S. & Razansky, D.: Volumetric optoacoustic imaging unveils high-resolution patterns of acute and cyclic hypoxia in a murine model of breast cancer. Cancer Res. 79, 4767-4775 (2019)
5.
Shah, R.* ; Singh, S.J.* ; Eddy, K.* ; Filipp, F.V. & Chen, S.*: Concurrent targeting of glutaminolysis and metabotropic glutamate receptor 1 (GRM1) reduces glutamate bioavailability in GRM1(+) melanoma. Cancer Res. 79, 1799-1809 (2019)
6.
Lordick, F.* et al.: Heterogeneity of HER2 expression in gastric cancer (GC) leads to high deviation rates between local and central testing and hampers efficacy of anti-HER2 therapy: Survival results from the VARIANZ study. Cancer Res. 78 (2018)
7.
Magkrioti, C.* et al.: The autotaxin - lysophosphatidic acid axis promotes lung carcinogenesis. Cancer Res. 78, 3634-3644 (2018)
8.
Mueller, S.* et al.: Evolutionary trajectories and KRAS gene dosage define pancreatic cancer phenotypes. Cancer Res. 78 (2018)
9.
Mycielska, M.E.* et al.: Extracellular citrate affects critical elements of cancer cell metabolism and supports cancer development in vivo. Cancer Res. 78, 2513-2523 (2018)
10.
Schirmer, D.* et al.: GPR64-specific CAR-transgenic T cells selectively kill Ewing sarcoma in vivo. Cancer Res. 78 (2018)
11.
Vreka, M. et al.: IkB kinase a Is required for development and progression of KRAS-mutant lung adenocarcinoma. Cancer Res. 78, 2939-2951 (2018)
12.
Wierling, C.* et al.: CanPathPro-development of a platform for predictive pathway modelling using genetically engineered mouse models. Cancer Res. 78 (2018)
13.
Zoni, E.* et al.: Metabolic signature in lethal vs. nonlethal prostate cancer. Cancer Res. 78, 61-62 (2018)
14.
Gires, O.: EGFR-dependent regulated intramembrane proteolysis of EpCAM - Letter. Cancer Res. 77, 1775-1776 (2017)
15.
Koch, M. et al.: Threshold analysis and biodistribution of fluorescently labeled bevacizumab in human breast cancer. Cancer Res. 77, 623-631 (2017)
16.
Schlenker, R. et al.: Chimeric PD-1:28 receptor upgrades low-avidity T cells and restores effector function of tumor-infiltrating lymphocytes for adoptive cell therapy. Cancer Res. 77, 3577-3590 (2017)
17.
Fehringer, G.* et al.: Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations. Cancer Res. 76, 5103-5114 (2016)
18.
González-Valllinas, M.* et al.: Abstract 1945: Identification of a miRNA/mRNA network driving non-small cell lung cancer (NSCLC) dissemination. Cancer Res. 76 (2016)
19.
Hatzl, S.* et al.: Increased expression of miR-23a mediates a loss of expression in the RAF kinase inhibitor protein RKIP. Cancer Res. 76, 3644-3654 (2016)
20.
Mall, S.* et al.: Immuno-PET imaging of engineered human T cells in tumors. Cancer Res. 76, 4113-4123 (2016)